ADIL vs ROL · $6.0M cap vs P/E 41, rev $1.99B
Adial Pharmaceuticals Inc (ADIL) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
Rollins Inc (ROL) is a personal services company listed on NYSE.
ADIL does not have a complete income-statement cache yet.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ADIL currently screens at market cap $6.0M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ADIL and ROL stock pages for the full models.
Not investment advice.